Probiotics and Coronavirus disease 2019: think about the link
Authors:
Open Access
- 14 September 2020
- journal article
- research article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 126 (10) , 1564-1570
Abstract
The pandemic of Coronavirus disease 2019 (COVID-19) is rapidly progressing, causing significant morbidity and mortality. Various antiviral drugs, anti-inflammatory drugs and immunomodulators have been tried without substantial clinical benefits. The severe and critical cases of COVID-19 disease are characterised by gut microbiome dysbiosis, immune dysregulation, hyper-inflammation and hypercytokinaemia (cytokine storm). Therefore, the strategies which target these pathophysiological processes may be beneficial. Probiotics are one such strategy that exerts beneficial effects by manipulation of the gut microbiota, suppression of opportunistic pathogens in the gut, decreasing translocation of opportunistic organisms, activation of mucosal immunity and modulation of the innate and adaptive immune response. Probiotics are the potential candidates to be tested in moderate and severe cases of COVID-19 due to several beneficial effects, including easy availability, easy to administer, safe and economical to use.Keywords
This publication has 110 references indexed in Scilit:
- Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infectionBMC Immunology, 2013
- Gut Microbial Translocation in Critically Ill Children and Effects of Supplementation with Pre- and Pro BioticsInternational Journal of Microbiology, 2012
- Pulmonary-intestinal cross-talk in mucosal inflammatory diseaseMucosal Immunology, 2011
- Probiotics for preventing ventilator-associated pneumonia2011
- Evaluation of the preventative effects exerted byLactobacillus fermentumin an experimental model of septic shock induced in miceBritish Journal of Nutrition, 2008
- Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patientsClinical Nutrition, 2007
- Probiotics for the prevention of Clostridium difficile associated diarrhea in adults2006
- A prospective randomised trial of probiotics in critically ill patientsClinical Nutrition, 2005
- Pathogenic relevance of Lactobacillus: a retrospective review of over 200 casesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- LactobacillusBacteremia, Clinical Significance, and Patient Outcome, with Special Focus on ProbioticL. RhamnosusGGClinical Infectious Diseases, 2004